SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+11.87%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$807M
AUM Growth
+$807M
(+16%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
18.35%
Top 10 Holdings %
Top 10 Hldgs %
42.29%
Holding
104
New
31
Increased
25
Reduced
14
Closed
27
Top Buys
| 1 |
Smith & Nephew
SNN
|
$27.1M |
| 2 |
SI-BONE Inc
SIBN
|
$20.9M |
| 3 |
Rigel Pharmaceuticals
RIGL
|
$16.9M |
| 4 |
Natera
NTRA
|
$16.3M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$15.9M |
Top Sells
| 1 |
CVRx
CVRX
|
$18.6M |
| 2 |
Vericel Corp
VCEL
|
$17.1M |
| 3 |
Eli Lilly
LLY
|
$14.3M |
| 4 |
HCA Healthcare
HCA
|
$8.29M |
| 5 |
Krystal Biotech
KRYS
|
$8.25M |
Sector Composition
| 1 | Healthcare | 97.15% |
| 2 | Consumer Staples | 1.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
MDxHealth
MDXH
$178M
| $194K | 0.02% |
+60,000
| New | +$194K |
|
77
AnaptysBio
ANAB
$630M
| – | – |
-14,727
| Closed | -$456K |
|
|
JBIO
78
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| – | – |
-217,119
| Closed | -$6.36M |
|
79
CRISPR Therapeutics
CRSP
$4.82B
| – | – |
-22,000
| Closed | -$894K |
|
80
DexCom
DXCM
$30.9B
| – | – |
-40,000
| Closed | -$4.53M |
|
|
81
CVRx
CVRX
$204M
| – | – |
-1,014,640
| Closed | -$18.6M |
|
82
Enovis
ENOV
$1.75B
| – | – |
-95,000
| Closed | -$5.08M |
|
83
Establishment Labs
ESTA
$1.11B
| – | – |
-39,920
| Closed | -$2.62M |
|
|
84
HCA Healthcare
HCA
$95.4B
| – | – |
-34,550
| Closed | -$8.29M |
|
85
Illumina
ILMN
$15.2B
| – | – |
-24,262
| Closed | -$4.91M |
|
86
Intuitive Surgical
ISRG
$158B
| – | – |
-9,600
| Closed | -$2.55M |
|
87
OrthoPediatrics
KIDS
$524M
| – | – |
-7,471
| Closed | -$297K |
|
|
88
Eli Lilly
LLY
$661B
| – | – |
-39,100
| Closed | -$14.3M |
|
89
Neogen
NEOG
$1.24B
| – | – |
-143,500
| Closed | -$2.19M |
|
90
Orthofix Medical
OFIX
$583M
| – | – |
-295,300
| Closed | -$6.06M |
|
91
Penumbra
PEN
$10.5B
| – | – |
-9,300
| Closed | -$2.07M |
|
92
PepGen
PEPG
$39M
| – | – |
-10,000
| Closed | -$134K |
|
93
Protagonist Therapeutics
PTGX
$3.62B
| – | – |
-236,000
| Closed | -$2.57M |
|
94
Avidity Biosciences
RNA
$6.12B
| – | – |
-310,000
| Closed | -$6.88M |
|
95
STAAR Surgical
STAA
$1.35B
| – | – |
-110,200
| Closed | -$5.35M |
|
96
10x Genomics
TXG
$1.66B
| – | – |
-70,000
| Closed | -$2.55M |
|
97
Ventyx Biosciences
VTYX
$184M
| – | – |
-69,000
| Closed | -$2.26M |
|
98
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
99
Xenon Pharmaceuticals
XENE
$2.99B
| – | – |
-38,000
| Closed | -$1.5M |
|
|
CUTR
100
DELISTED
Cutera, Inc.
CUTR
| – | – |
-20,000
| Closed | -$884K |
|